研究者

J-GLOBAL ID：201201080067266940 更新日: 2023年06月27日

中島英行

ナカシマヒデユキ | Hideyuki Nakashima

ホームページURL (1件)： http://kaken.nii.ac.jp/d/r/30437032.ja.html

研究分野 (1件)：病態系口腔科学

論文 (14件)：

Sato I, Umemura M, Mitsudo K, Kioi M, Nakashima H, Iwai T, Feng X, Oda K, Miyajima A, Makino A, et al. Hyperthermia generated with ferucarbotran (Resovist®) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells. The journal of physiological sciences : JPS. 2014. 64. 3. 177-183
Kenji Mitsudo, Toshiyuki Koizumi, Masaki Iida, Toshinori Iwai, Hideyuki Nakashima, Senri Oguri, Mitomu Kioi, Makoto Hirota, Izumi Koike, Masaharu Hata, et al. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: Analysis of therapeutic results in 112 cases. RADIOTHERAPY AND ONCOLOGY. 2014. 111. 2. 306-310
Hall B, Nakashima H, Sun ZJ, Sato Y, Bian Y, Husain SR, Puri RK, Kulkarni AB. Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling. Journal of translational medicine. 2013. 11. 45
Hideyuki Nakashima, Kotaro Miyake, Christopher R. Clark, Joseph Bekisz, Joel Finbloom, Syed R. Husain, Samuel Baron, Raj K. Puri, Kathryn C. Zoon. Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors. CANCER IMMUNOLOGY IMMUNOTHERAPY. 2012. 61. 7. 1081-1092
Hideyuki Nakashima, Syed R. Husain, Raj K. Puri. IL-13 receptor-directed cancer vaccines and immunotherapy. IMMUNOTHERAPY. 2012. 4. 4. 443-451

もっと見る

MISC (2件)：

経歴 (1件)：

2012 - 横浜市立大学大学病院その他

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM